Increased risk of acute arterial events in young patients and severely active IBD: A nationwide French cohort study

Gut

Volumn 67, Issue 7, 2018, Pages 1261-1268

  Kirchgesner, Julien ^a,b   Beaugerie, Laurent ^a,c   Carrat, Fabrice ^a,b   Andersen, Nynne Nyboe ^d,e   Jess, Tine ^d,e,f   Schwarzinger, Michaël ^g,h   Bouvier, Anne Marie ⁱ   Buisson, Anne ⁱ   Carbonnel, Franck ⁱ   Cosnes, Jacques ⁱ   Gower Rousseau, Corinne ⁱ   Olympie, Alain ⁱ   Peyrin Biroulet, Laurent ⁱ   Rahier, Jean François ⁱ   Ruemmele, Frank ⁱ   Simon, Tabassome ⁱ   Yazdanpanah, Yazdan ⁱ  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^c INSERM   (France)

^d STATENS SERUM INSTITUT   (Denmark)

^e ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^f BISPEBJERG HOSPITAL   (Denmark)

^g Translational Health Economics Network   (France)

^h UNIVERSITÉ PARIS DIDEROT   (France)

ⁱ NONE

Author keywords

cardiovascular disease; cerebrovascular disease; Inflammatory bowel disease; ischemic heart disease; peripheral arterial disease

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRANCE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; ULCERATIVE COLITIS; ADOLESCENT; AGE; AGED; COMPLICATION; FACTUAL DATABASE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; YOUNG ADULT;

EID: 85026306761     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-314015     Document Type: Article

References (44)

1. Hansson GK, Inflammation HGK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
2. Shankar A, Li J, Nieto FJ, et al. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 2007;154:495-501.
3. Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524-9.
4. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.
5. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011;7:399-408.
6. Singh S, Singh H, Loftus EV, Ev LJ, et al. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12:382-93.
7. Fumery M, Xiaocang C, Dauchet L, et al. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014;8:469-79.
8. Rungoe C, Basit S, Ranthe MF, et al. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide danish cohort study. Gut 2013;62:689-94.
9. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:41-5.
10. Andersohn F, Waring M, Garbe E. Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflamm Bowel Dis 2010;16:1387-92.
11. Ha C, Magowan S, Accortt NA, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104:1445-51.
12. Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a danish nationwide cohort study. PLoS One 2013;8:e56944.
13. ATI H. Agence technique de l'information sur l'hospitalisation. Programme de médicalisation des systèmes d'information (PMSI), présentation http://www.atih. sante. fr/mco/presentation? secteur= MCO (accessed 28 Dec 2015).
14. IN SEE Institut national de la statistique et des études économiques. Répartition desDes décès selon le lieu duDu décès [Distribution of deaths according to location]: Institut national de la statistique et des études économiques;.2014 http://insee. fr/fr/themes/detail. asp? reg-id= 0&ref-id= ir-irsocsd20133 - IRSOCSD20133-SERIE. (accessed 28 Dec 2015).
15. Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997;9:1213-7.
16. Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis 2005;11:304-13.
17. Landesberg G, Beattie WS, Mosseri M, et al. Perioperative myocardial infarction. Circulation 2009;119:2936-44.
18. Rein P, Saely CH, Silbernagel G, et al. Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease. Atherosclerosis 2015;239:299-303.
19. Singh S, Kullo IJ, Pardi DS, et al. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol 2015;12:26-35.
20. Wu GC, Leng RX, Lu Q, et al. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology 2017;68:447-61.
21. Zanoli L, Cannavò M, Rastelli S, et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012;30:1775-81.
22. Roifman I, Sun YC, Fedwick JP, et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:175-82.
23. Fagan EA, Dyck RF, Maton PN, et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-9.
24. Saverymuttu SH, Hodgson HJ, Chadwick VS, et al. Differing acute phase responses in Crohn's disease and ulcerative colitis. Gut 1986;27:809-13.
25. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. results from a prospective population-based study. Gut 2008;57:1518-23.
26. Gross V, Andus T, Caesar I, et al. Evidence for continuous stimulation of interleukin-6 production in crohn's disease. Gastroenterology 1992;102:514-9.
27. Oussalah A, Guéant JL, Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 2011;34:1173-84.
28. Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 2003;98:112-7.
29. Galluzzo S, Patti G, Dicuonzo G, et al. Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study. Hum Immunol 2011;72:636-40.
30. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for crohn's disease on chromosome 16. Nature 1996;379:821-3.
31. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology 2006;130:650-6.
32. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990;98:104-10.
33. Loftus CG, Loftus EV, Harmsen WS, et al. Update on the incidence and prevalence of crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-61.
34. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11.
35. Couris CM, Polazzi S, Olive F, et al. Breast Cancer incidence using administrative data: correction with sensitivity and specificity. J Clin Epidemiol 2009;62:660-6.
36. Chantry AA, Deneux-Tharaux C, Cans C, et al. Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity. J Clin Epidemiol 2011;64:1014-22.
37. Uhry Z, Remontet L, Colonna M, et al. Cancer incidence estimation at a district level without a national registry: a validation study for 24 Cancer sites using french health insurance and registry data. Cancer Epidemiol 2013;37:99-114.
38. Lorgis L, Cottenet J, Molins G, et al. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a french nationwide hospital medical information database. Circulation 2013;127:1767-74.
39. Sahli L, Lapeyre-Mestre M, Derumeaux H, et al. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the french national hospital database. Pharmacoepidemiol Drug Saf 2016;25:785-9.
40. Giroud M, Hommel M, Benzenine E, et al. Positive predictive value of french hospitalization Discharge Codes for Stroke and transient ischemic attack. Eur Neurol 2015;74:92-9.
41. SPF. Les cardiopathies ischémiques. incidence: Santé Publique France. http://invs. santepubliquefrance. fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Maladies-cardio-neuro-vasculaires/Les-cardiopathies-ischemiques (accessed 2 Apr2017).
42. Seksik P, Nion-Larmurier I, Sokol H, et al. Effects of light smoking consumption on the clinical course of crohn's disease. Inflamm Bowel Dis 2009;15:734-41.
43. Berthier N, Guignard R, Richard J, et al. Regional comparison of tobacco smoking and e-cigarette use in France in 2014. Bull Epidémiol Hebd 2016:30508-3114.
44. Kirchgesner J, Lemaitre M, Rudnichi A, et al. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the french administrative health databases 2009-2014. Aliment Pharmacol Ther 2017;45:37-49.